Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-015419
Filing Date
2025-02-06
Accepted
2025-02-06 16:30:08
Documents
1
Period of Report
2025-02-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6440
  Complete submission text file 0000950170-25-015419.txt   7995
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Issuer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MEREO BIOPHARMA 1 CAVENDISH PLACE LONDON X0 W1G 0QF
Business Address
Ekblom Anders (Reporting) CIK: 0002005817 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38452 | Film No.: 25597814